### ğŸ« Pulm/CC: Screening for lung cancer in high-risk patients

#### âœ… True Statements
1. The **U.S. Preventive Services Task Force (USPSTF)** recommends **annual lung cancer screening with low-dose CT** in patients aged **50 to 80 years** who have **at least a 20-pack-year smoking history**, including those who quit within the past 15 years.  
2. **Lung cancer screening** should be stopped once a patient has not smoked for **15 years**, or if the patient has **limited life expectancy** or would not undergo surgery.  
3. The **American Cancer Society (ACS)** recommends screening all patients with a smoking history who meet the criteria, regardless of when they last smoked.  
4. **Chest radiography** is not recommended for lung cancer screening, as studies have failed to show benefit.  
5. The **National Lung Screening Trial** demonstrated a **20% reduction in lung cancer mortality** in high-risk patients screened annually with low-dose CT compared with chest radiography.  
6. **Sputum cytology** should not be used for lung cancer screening.  
7. The **NELSON trial** and the **National Lung Screening Trial** both demonstrated that low-dose CT screening reduces lung cancer mortality.  
8. **Key Point:** The USPSTF recommends annual low-dose CT lung cancer screening in patients aged 50 to 80 years with a 20-pack-year smoking history, including those who quit within the past 15 years. Chest radiography and sputum cytology should not be used.

#### ğŸ’¬ Extra(s)
1. Screening should not be delayed until age 60 years, because the USPSTF recommends initiating screening at age 50 years.  

#### ğŸ“š Reference
Krist AH, Davidson KW, Mangione CM, et al; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:962-70. PMID: 33687470 doi:10.1001/jama.2021.1117

#### ğŸ·ï¸ Tags
#Pulm/CC #LungCancer #Screening #USPSTF #LowDoseCT #Prevention #AmbulatoryCare

#### ğŸ†” Question ID
PMMCQ24025

#### ğŸ•’ Last Updated
February 2025

---

#### ğŸ“– Related Text
MKSAP: Pulmonary Medicine, Lung Tumors, Lung Cancer, Lung Cancer Screening

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements
1. Before 2013, lung cancer screening was not widely performed because earlier studies did not show a mortality benefit.  
2. The **National Lung Screening Trial** demonstrated a **20% reduction in lung cancer mortality** in patients with a â‰¥30 pack-year history screened annually for 3 years.  
3. The USPSTF recommends **annual lung cancer screening with low-dose CT in high-risk patients** (grade B recommendation).  
4. Screening should be performed in patients aged **50 through 80 years** who have **no symptoms of lung cancer** and at least a **20-pack-year smoking history**.  
5. The USPSTF recommends **stopping screening** once a patient has not smoked for **15 years**, has **limited life expectancy**, or would not undergo surgery.  
6. The **American Cancer Society** recommends screening all patients with a smoking history who meet criteria, regardless of when they last smoked.  

#### ğŸ’¬ Extra(s)
<!-- None -->

#### ğŸ·ï¸ Related Text Tags
#Pulm/CC #LungCancer #Screening #USPSTF #ACS #LowDoseCT
